dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
dNP2 is a blood–brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-15
DOI
10.1038/ncomms9244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New FDA-Approved Disease-Modifying Therapies for Multiple Sclerosis
- (2015) Clayton English et al. CLINICAL THERAPEUTICS
- Oral Disease-Modifying Therapies for Multiple Sclerosis
- (2015) Woojun Kim et al. Journal of Clinical Neurology
- Drug therapy for multiple sclerosis
- (2014) E. Tavazzi et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- The connexin43 mimetic peptide Gap19 inhibits hemichannels without altering gap junctional communication in astrocytes
- (2014) Verónica Abudara et al. Frontiers in Cellular Neuroscience
- Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation
- (2013) Chang Hee Kim et al. CELL CYCLE
- Using EAE to better understand principles of immune function and autoimmune pathology
- (2013) Manu Rangachari et al. JOURNAL OF AUTOIMMUNITY
- The B7-Independent Isoform of CTLA-4 Functions To Regulate Autoimmune Diabetes
- (2013) M. Stumpf et al. JOURNAL OF IMMUNOLOGY
- Brief Report: Increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lprmice
- (2012) Kunihiro Ichinose et al. ARTHRITIS AND RHEUMATISM
- Expression and purification of human TAT-p53 fusion protein in Pichia pastoris and its influence on HepG2 cell apoptosis
- (2012) Haowei Yan et al. BIOTECHNOLOGY LETTERS
- Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
- (2012) Jieun Lee et al. CELL
- Mechanisms regulating regional localization of inflammation during CNS autoimmunity
- (2012) Emily Pierson et al. IMMUNOLOGICAL REVIEWS
- Identification of a novel cell-penetrating peptide from human phosphatidate phosphatase LPIN3
- (2012) Sangho Lim et al. MOLECULES AND CELLS
- Cell-penetrating peptides: breaking through to the other side
- (2012) Erez Koren et al. TRENDS IN MOLECULAR MEDICINE
- Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure
- (2012) James C Geoghegan et al. Molecular Therapy-Nucleic Acids
- Modern methods for delivery of drugs across the blood–brain barrier
- (2011) Yan Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- Phagocytic Clearance in Neurodegeneration
- (2011) Jennifer D. Sokolowski et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein transduction domain delivery of therapeutic macromolecules
- (2011) Arjen van den Berg et al. CURRENT OPINION IN BIOTECHNOLOGY
- Overexpression of the CTLA-4 Isoform Lacking Exons 2 and 3 Causes Autoimmunity
- (2011) S. M. Liu et al. JOURNAL OF IMMUNOLOGY
- A Novel LZAP-binding Protein, NLBP, Inhibits Cell Invasion
- (2010) Junhye Kwon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting bcr–abl fusion gene in Chronic Myeloid Leukemia cells
- (2010) Yamini Arthanari et al. JOURNAL OF CONTROLLED RELEASE
- I-TASSER: a unified platform for automated protein structure and function prediction
- (2010) Ambrish Roy et al. Nature Protocols
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression
- (2009) Melissa J. Simon et al. BIOTECHNOLOGY AND BIOENGINEERING
- Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction
- (2009) Jacob M. Gump et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic Evidence That the Differential Expression of the Ligand-Independent Isoform of CTLA-4 Is the Molecular Basis of the Idd5.1 Type 1 Diabetes Region in Nonobese Diabetic Mice
- (2009) M. Araki et al. JOURNAL OF IMMUNOLOGY
- Efficient siRNA delivery into primary cells by a peptide transduction domain–dsRNA binding domain fusion protein
- (2009) Akiko Eguchi et al. NATURE BIOTECHNOLOGY
- Interferon- mechanisms of action in multiple sclerosis
- (2009) S. Dhib-Jalbut et al. NEUROLOGY
- CNS Delivery Via Adsorptive Transcytosis
- (2008) Françoise Hervé et al. AAPS Journal
- Ultrasound for drug and gene delivery to the brain
- (2008) Kullervo Hynynen ADVANCED DRUG DELIVERY REVIEWS
- I-TASSER server for protein 3D structure prediction
- (2008) Yang Zhang BMC BIOINFORMATICS
- Transduction of the cytoplasmic domain of CTLA-4 inhibits TcR-specific activation signals and prevents collagen-induced arthritis
- (2008) J.-M. Choi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 trafficking and surface expression
- (2008) Elke Valk et al. TRENDS IN IMMUNOLOGY
- Thermodynamic studies and binding mechanisms of cell-penetrating peptides with lipids and glycosaminoglycans
- (2007) André Ziegler ADVANCED DRUG DELIVERY REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started